Overview
U.S. body contouring provider's Q1 revenue was flat yr/yr, case volume up 0.2%
Adjusted EPS for Q1 improved yr/yr, adjusted EBITDA declined
Company reaffirmed full-year 2026 revenue and adjusted EBITDA guidance
Outlook
Company reaffirms 2026 revenue guidance of $151 mln to $157 mln
Company maintains 2026 adjusted EBITDA outlook of $15 mln to $17 mln
AirSculpt expects seasonally strong Q2 driven by enhanced sales and marketing initiatives
Result Drivers
SAME-CENTER SALES - Co said Q1 revenue was stabilized by positive same-center sales growth
SALES & MARKETING INITIATIVES - Co attributed building same-center sales to enhanced and elevated sales and marketing initiatives
Company press release: ID:nGNX61zK92
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Slight Beat*
$39.40 mln
$39.25 mln (2 Analysts)
Q1 Adjusted EPS
Beat
-$0.01
-$0.02 (2 Analysts)
Q1 Net Income
-$2.40 mln
Q1 Adjusted EBITDA
Miss
$3.30 mln
$3.35 mln (2 Analysts)
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for AirSculpt Technologies Inc is $3.00, about 13.3% below its May 7 closing price of $3.46
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)